Primary Site >> Biliary tract Cancer
Gene >> SLC22A16
|
|
|
|
|---|---|---|---|
|
Ref: Feasibility and benefits of second-line chemotherapy in advanced biliary tract cancer: a large retrospective study. PMID: 22947649 |
Ref: Prognostic Factors for the Selection of Patients Eligible for Second-Line Chemotherapy in Advanced Biliary Tract Cancer. PMID: 25720697 |
Ref: Second-line chemotherapy for advanced biliary tract cancer after failure of the gemcitabine-platinum combination: A large multicenter study by the Association des Gastro-Enterologues Oncologues. PMID: 26052689 |
Ref: Resection of Hepatic Lesions Perfused by the Cholecystic Vein Using Indocyanine Green Navigation in Patients with cT2 Gallbladder Cancer. PMID: 30267293 Ref: Second-line chemotherapy in patients with advanced or recurrent biliary tract cancer: a single center, retrospective analysis of 294 cases. PMID: 30324343 |